These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 11366080)
1. Are men and women really different? Res Initiat Treat Action; 1998 Dec; 4(7):13. PubMed ID: 11366080 [TBL] [Abstract][Full Text] [Related]
2. Do women respond differently to HIV therapy than men? Newsline People AIDS Coalit N Y; 1998 Dec; ():31. PubMed ID: 11367087 [TBL] [Abstract][Full Text] [Related]
3. Soft gel saquinavir has high exposure. AIDS Alert; 1997 Dec; 12(12):143-4. PubMed ID: 11364835 [TBL] [Abstract][Full Text] [Related]
4. New study of Fortovase (Saquinavir) in women. WORLD; 1998 Nov; (No 91):4. PubMed ID: 11365973 [TBL] [Abstract][Full Text] [Related]
5. New formulation of saquinavir (Fortovase) is more effective. Tam CW Fac Notes (New Orleans La); 1998; 10(2):11. PubMed ID: 11365126 [TBL] [Abstract][Full Text] [Related]
6. Improved but not new. Vazquez E Posit Aware; 1997; 8(6):19. PubMed ID: 11364855 [TBL] [Abstract][Full Text] [Related]
7. Long-term efficacy and safety of twice-daily saquinavir soft gelatin capsules (SGC), with or without nelfinavir, and three times daily saquinavir-SGC, in triple combination therapy for HIV infection: 100-week follow-up. Greenberg RN; Feinberg J; Goodrich J; Pilson RS; Siemon-Hryczyk P Antivir Ther; 2003 Feb; 8(1):37-42. PubMed ID: 12713062 [TBL] [Abstract][Full Text] [Related]
9. Saquinavir, the pioneer antiretroviral protease inhibitor. la Porte CJ Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1313-22. PubMed ID: 19737048 [TBL] [Abstract][Full Text] [Related]
10. Lottery opens 2,000 slots for protease trial. AIDS Alert; 1995 Nov; 10(11):144. PubMed ID: 11362929 [TBL] [Abstract][Full Text] [Related]
14. Fortovase approved: new saquinavir formulation. James JS AIDS Treat News; 1997 Nov; (No 283):1. PubMed ID: 11364907 [TBL] [Abstract][Full Text] [Related]
15. Protease inhibitors at a glance... Notes Undergr; 1998-1999 Winter; (No 38):suppl 1-4. PubMed ID: 11366198 [TBL] [Abstract][Full Text] [Related]
16. Study to address effects of antiretroviral therapy on women. Hanna L BETA; 1999 Apr; 12(2):16. PubMed ID: 11366677 [TBL] [Abstract][Full Text] [Related]
17. What they say about protease inhibitors. Posit Aware; 1999; 10(1):38-43. PubMed ID: 11366522 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of twice-daily versus three-times daily saquinavir soft gelatin capsules as part of triple combination therapy for HIV-1 infection. Wheat LJ; Farthing C; Cohen C; Pierone G; Lalezari J; Pilson RS; Siemon-Hryczyk P; Antivir Ther; 2002 Sep; 7(3):199-209. PubMed ID: 12487388 [TBL] [Abstract][Full Text] [Related]
19. Protease inhibitor update. Colvin R; Haas G Common Factor; 1995 Apr; (no 10):15. PubMed ID: 11362340 [TBL] [Abstract][Full Text] [Related]
20. LaCARP seeks patients for study that will compare protease inhibitors. Fac Notes (New Orleans La); 1998; 10(6):6. PubMed ID: 11366144 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]